117 related articles for article (PubMed ID: 32159245)
1. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM.
Ji W; Xie X; Bai G; He Y; Li L; Zhang L; Qiang D
Mol Omics; 2024 Jun; 20(5):333-347. PubMed ID: 38686662
[TBL] [Abstract][Full Text] [Related]
3. Investigating the mechanism of cornel iridoid glycosides on type 2 diabetes mellitus using serum and urine metabolites in rats.
Hou Y; Huang Y; Shang Z; Ma S; Cui T; Chen A; Cui Y; Chen S
J Ethnopharmacol; 2024 Jun; 328():118065. PubMed ID: 38508432
[TBL] [Abstract][Full Text] [Related]
4. Untargeted Metabolomics Based on Ultra-High-Performance Liquid Chromatography Coupled with Quadrupole Orbitrap High-Resolution Mass Spectrometry for Differential Metabolite Analysis of Pinelliae Rhizoma and Its Adulterants.
Wang J; Cui J; Liu Z; Yang Y; Li Z; Liu H
Molecules; 2024 May; 29(9):. PubMed ID: 38731650
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
6. Study on pulp metabolism of patients with pulpitis using ultra-performance liquid chromatography coupled with Orbitrap mass spectrometry.
Guo K; Xu X; Gao J; Zhang Y; Wang Y; Zhuang Y; Zhu Y; Zhou Z; Chen X; Zhang Z; Wei W
Clin Chim Acta; 2024 May; 558():117894. PubMed ID: 38583552
[TBL] [Abstract][Full Text] [Related]
7. Untargeted metabolomics reveals potential plasma biomarkers for diagnosis of primary aldosteronism using liquid chromatography-mass spectrometry.
Song JJ; Cai J; Ma WJ; Lou Y; Bian J; Zhao B; She X; Liu XN
Biomed Chromatogr; 2024 Jun; 38(6):e5855. PubMed ID: 38442715
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of change in metabolome caused by comprehensive diabetes treatment: A prospective observational study of diabetes inpatients with gas chromatography/mass spectrometry-based non-target metabolomic analysis.
Taya N; Katakami N; Omori K; Arakawa S; Hosoe S; Watanabe H; Takahara M; Miyashita K; Nishizawa H; Matsuoka TA; Furuno M; Bamba T; Iida J; Fukusaki E; Shimomura I
J Diabetes Investig; 2021 Dec; 12(12):2232-2241. PubMed ID: 34032389
[TBL] [Abstract][Full Text] [Related]
9. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers for frailty diagnosis via serum amino acids metabolomic analysis using UPLC-MS/MS.
Zhou M; Sun W; Chu J; Liao Y; Xu P; Chen X; Li M
Proteomics Clin Appl; 2024 May; 18(3):e2300035. PubMed ID: 38196151
[TBL] [Abstract][Full Text] [Related]
11. Discovery of antitussive material basis and mechanisms in Citri Sarcodactylis Fructus by coupling UHPLC-Q/Orbitrap HRMS combined spectrum-effect relationship and metabolomics analyses.
Li X; Liu X; Gong Q; Duan T; Zhang M; Guo D; Wu W; Deng F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123987. PubMed ID: 38211391
[TBL] [Abstract][Full Text] [Related]
12. Unveiling novel metabolic alterations in postmenopausal osteoporosis and type 2 diabetes mellitus through NMR-based metabolomics: A pioneering approach for identifying early diagnostic markers.
Kaur S; Kumari P; Singh G; Joshi N; Kaur T; Dhiman V; Singh G; Sachdeva N; Kumar D; Barnwal RP; Bhadada SK
J Proteomics; 2024 Jun; 302():105200. PubMed ID: 38772440
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus.
Luo T; Jiang X; Xu N; Zhao X; Xie X; Xia X; Bian X; Liu H
Front Mol Biosci; 2024; 11():1341290. PubMed ID: 38698772
[No Abstract] [Full Text] [Related]
14. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
15. A widely targeted metabolite modificomics strategy for modified metabolites identification in tomato.
Yang J; Chen R; Wang C; Li C; Ye W; Zhang Z; Wang S
J Integr Plant Biol; 2024 Apr; 66(4):810-823. PubMed ID: 38375781
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis.
Jabbar Al-Rikabi SA; Etemadi A; Morad MM; Nowrouzi A; Panahi GS; Mondeali M; Toorani-Ghazvini M; Nasli-Esfahani E; Razi F; Bandarian F
Endocrinol Diabetes Metab; 2024 May; 7(3):e00484. PubMed ID: 38739122
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus.
Wang T; Li C; Ma Y; Zhou H; Du X; Li Y; Long S; Ding Y; Lu G; Chen W; Zhou Y; Yu L; Wang J; Wang Y
CNS Neurosci Ther; 2023 Dec; 29(12):3925-3934. PubMed ID: 37381696
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.
Patterson AD; Bonzo JA; Li F; Krausz KW; Eichler GS; Aslam S; Tigno X; Weinstein JN; Hansen BC; Idle JR; Gonzalez FJ
J Biol Chem; 2011 Jun; 286(22):19511-22. PubMed ID: 21487016
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
Guertin KA; Moore SC; Sampson JN; Huang WY; Xiao Q; Stolzenberg-Solomon RZ; Sinha R; Cross AJ
Am J Clin Nutr; 2014 Jul; 100(1):208-17. PubMed ID: 24740205
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential serum biomarkers associated with HbA1c levels in Indian type 2 diabetic subjects using NMR-based metabolomics.
Yousf S; Batra HS; Jha RM; Sardesai DM; Ananthamohan K; Chugh J; Sharma S
Clin Chim Acta; 2024 Apr; 557():117857. PubMed ID: 38484908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
